About: Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) article scientifique publié en 2005 (fr) наукова стаття, опублікована в листопаді 2005 (uk) im Juni 2005 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q56902548-4BD7A051-E76C-454D-AD53-744316B9FB8E
publication date	2005-06-16 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q56902548-D6EE1742-BAEB-45D2-99B7-8BC6C29CC716
language of work or name	English
exact match	wds:Q56902548-09A5DA6F-903B-4AC2-BDCE-4CE3ED95B04F
exact match	https://scigraph.springernature.com/pub.10.1007/s00262-005-0670-9
cites work	wds:Q56902548-AB606C74-4D94-4699-AB98-C63272A879EF wds:Q56902548-B3794144-3262-48F2-B64C-8672E065579A
cites work	Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants
author name string	wds:Q56902548-321FB366-6E5D-42B5-B03F-7D0102D736A8 wds:Q56902548-39E0D115-1022-4709-B302-738F7BE0ADDD wds:Q56902548-86F4393F-DA1D-44FB-AAA1-FA669756BE37 wds:Q56902548-9E40B4C6-72FC-4D10-81C6-1BD30114D763 wds:Q56902548-AA2CD972-735D-48A0-8C05-8CB749FB8238
author name string	Theresa L Whiteside Kazuaki Chikamatsu Robert L Ferris Albert B DeLeo Grace G Kim
rdfs:label	Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (en) Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (nl)
skos:prefLabel	Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (en) Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (nl)
name	Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (en) Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (nl)
author	wds:Q56902548-B0AA1A9D-4C2A-40A3-B110-99488486C87B
author	Andreas E. Albers
title	wds:Q56902548-E78E5E95-A63F-4115-9CC4-767CB5066106
title	Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites (en)
page(s)	wds:Q56902548-9D19E802-95EE-43D0-879E-580AD2AA7C54
page(s)	1072-1081
instance of	wds:Q56902548-7B766B45-B0C3-417B-BE7C-A8764C97DC37
instance of	scholarly article
PubMed ID	wds:Q56902548-9AEAEDD0-5266-46E6-B322-806087A9E4CB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15959774
PubMed ID	15959774
published in	wds:Q56902548-CCFE75A4-B7F2-4D15-951E-7BE9228BEF1F
published in	Cancer Immunology, Immunotherapy
issue	wds:Q56902548-53B8576A-A3F3-4C3B-8170-71409958A6A1
volume	wds:Q56902548-07193A18-D570-43E9-8B11-0D25470E43C9
issue	11
volume	54
DOI	wds:Q56902548-DB3A2C53-9FDD-4383-BC92-37E194E251F6
DOI	http://dx.doi.org/10.1007/S00262-005-0670-9
DOI	10.1007/S00262-005-0670-9
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q56902548
is cites work of	An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease Tumour immunity: effector response to tumour and role of the microenvironment Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCR. The tumor microenvironment and its role in promoting tumor growth Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma Regulatory T cells: what role do they play in antitumor immunity in patients with head and neck cancer? Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer Stimulation of anti-tumor immunity by photodynamic therapy Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma Regulatory T cells and their prognostic value for patients with squamous cell carcinoma of the head and neck Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer Promising systemic immunotherapies in head and neck squamous cell carcinoma Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies T cell-tumor interaction directs the development of immunotherapies in head and neck cancer Toward the development of multi-epitope p53 cancer vaccines: an in vitro assessment of CD8(+) T cell responses to HLA class I-restricted wild-type sequence p53 peptides Phase I dendritic cell p53 peptide vaccine for head and neck cancer Development of multi-epitope vaccines targeting wild-type sequence p53 peptides Adoptive T-Cell Therapy for Solid Tumors Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer. Regulatory T cells function at the early stage of tumor progression in a mouse model of tongue squamous cell carcinoma Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. New Therapies in Head and Neck Cancer. Therapeutic use of Aldara in chronic myeloid leukemia P53 and expression of immunological markers may identify early stage thyroid tumors The mutational status of p53 can influence its recognition by human T-cells. Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer [Prophylactic and therapeutic vaccines against human papilloma virus]. Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival Immunotherapy of head and neck cancer. Current developments Antigen-specific immunotherapy in head and neck cancer
is cites work of	wds:Q37334966-FF52D108-1390-41AC-A842-D493B35AC125 wds:Q35574242-ACA7907B-0DD3-4ED9-857D-3993DC1472B7 wds:Q33927506-AD68349C-D10F-43F5-9050-3AAD8D7A57B8 wds:Q36527473-92DA00B8-272F-4353-B6BF-60D1AFDE2A07 wds:Q50999703-D491EED9-8174-437F-93FD-B7C202331DBC wds:Q36946019-45CB79F2-C494-48B2-A6D8-4FE61599BDB0 wds:Q41888065-FA6C983B-E051-4E61-AFA5-94BE09D70975

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software